Gene · 3822
Papers2,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,624
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Microphysiological model reveals the promise of memory-like natural killer cell immunotherapy for HIV± cancer. | Nat Commun | 2023 | 37865647 | PubTator, text mining | PubMed |
| Single-cell profiling reveals immune disturbances landscape and HLA-F-mediated immune tolerance at the maternal-fetal interface in preeclampsia. | Front Immunol | 2023 | 37854606 | PubTator, text mining | PubMed |
| Single-cell characterization of self-renewing primary trophoblast organoids as modeling of EVT differentiation and interactions with decidual natural killer cells. | BMC Genomics | 2023 | 37853336 | PubTator, text mining | PubMed |
| Trimodal single-cell profiling reveals a novel pediatric CD8αα+ T cell subset and broad age-related molecular reprogramming across the T cell compartment. | Nat Immunol | 2023 | 37845489 | PubTator, text mining | PubMed |
| In-depth characterization of NK cell markers from CML patients who discontinued tyrosine kinase inhibitor therapy. | Front Immunol | 2023 | 37818372 | PubTator, text mining | PubMed |
| Phenotype and fate of liver-resident CD8 T cells during acute and chronic hepacivirus infection. | PLoS Pathog | 2023 | 37812637 | PubTator, text mining | PubMed |
| Non-classical HLA-E restricted CMV 15-mer peptides are recognized by adaptive NK cells and induce memory responses. | Front Immunol | 2023 | 37809084 | PubTator, text mining | PubMed |
| OMIP-098: A 26 parameter, 24 color flow cytometry panel for human memory NK cell phenotyping. | Cytometry A | 2023 | 37807668 | PubTator, text mining | PubMed |
| NK cells from Men Who Have Sex with Men at high risk for HIV-1 infection exhibit higher effector capacity. | Sci Rep | 2023 | 37798386 | PubTator, text mining | PubMed |
| CCR5 drives NK cell-associated airway damage in pulmonary ischemia-reperfusion injury. | JCI Insight | 2023 | 37788115 | PubTator, text mining | PubMed |
| Intratumoral co-injection of NK cells and NKG2A-neutralizing monoclonal antibodies. | EMBO Mol Med | 2023 | 37782273 | PubTator, text mining | PubMed |
| ScRNA-seq revealed disruption in CD8+ NKG2A+ natural killer T cells in patients after liver transplantation and immunosuppressive therapy. | Immun Inflamm Dis | 2023 | 37773707 | PubTator, text mining | PubMed |
| Effect of high dose vitamin D3 on the HIV-1 reservoir: A pilot randomised controlled trial. | J Virus Erad | 2023 | 37753336 | PubTator, text mining | PubMed |
| Natural killer cells and their exosomes in viral infections and related therapeutic approaches: where are we? | Cell Commun Signal | 2023 | 37749597 | PubTator, text mining | PubMed |
| Application of cell-derived exosomes in the hematological malignancies therapy. | Front Pharmacol | 2023 | 37745073 | PubTator, text mining | PubMed |
| KLRG1 expression on natural killer cells is associated with HIV persistence, and its targeting promotes the reduction of the viral reservoir. | Cell Rep Med | 2023 | 37741278 | PubTator, text mining | PubMed |
| Mapping the chemotactic landscape in NK cells reveals subset-specific synergistic migratory responses to dual chemokine receptor ligation. | EBioMedicine | 2023 | 37741009 | PubTator, text mining | PubMed |
| Age-dependent acquisition of pathogenicity by SARS-CoV-2 Omicron BA.5. | Sci Adv | 2023 | 37738347 | PubTator, text mining | PubMed |
| Early expansion of activated adaptive but also exhausted NK cells during acute severe SARS-CoV-2 infection. | Front Cell Infect Microbiol | 2023 | 37712059 | PubTator, text mining | PubMed |
| Natural killer cells and BNT162b2 mRNA vaccine reactogenicity and durability. | Front Immunol | 2023 | 37711632 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3822/papers?page=13